adenosine diphosphate has been researched along with Bone Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, X; Li, F; Liu, J; Lu, A; Song, W; Wu, X; Xiao, GG; Zhang, G | 1 |
| Chen, J; Wang, L; Yang, J; Zhang, Y | 1 |
| Collins, L; Conley, PB; Craft, CS; Deng, H; Eagleton, MC; Floyd, DH; Grabowska, D; Heller, E; Hirbe, AC; Hughes, A; Hurchla, MA; Novack, DV; Piwnica-Worms, D; Rogers, M; Schneider, JG; Steinberg, TH; Su, X; Townsley, S; Uluckan, O; Weilbaecher, KN; Wu, K; Xiang, J; Zou, W | 1 |
| Crevel, I; Cross, R; DeBonis, S; Hackney, D; Kozielski, F; Lebeau, L; Saoudi, Y; Skoufias, DA; Wade, RH | 1 |
| Bijvoet, OL; Cleton, FJ; van Holten-Verzantvoort, AT | 1 |
| Stevens, MJ | 1 |
1 trial(s) available for adenosine diphosphate and Bone Neoplasms
| Article | Year |
|---|---|
Effect of long-term bisphosphonate treatment on morbidity due to bone metastases in breast cancer patients.
Topics: Adenosine Diphosphate; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Hypercalcemia; Multicenter Studies as Topic; Pain; Radiography; Random Allocation | 1989 |
5 other study(ies) available for adenosine diphosphate and Bone Neoplasms
| Article | Year |
|---|---|
Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by boosting ezrin phosphorylation.
Topics: Adenosine Diphosphate; Animals; Bone Neoplasms; Cytoskeletal Proteins; Lung Neoplasms; Mice; Osteosarcoma; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Ribose | 2022 |
P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
Topics: Adenosine Diphosphate; Animals; Bone Neoplasms; Carcinoma 256, Walker; Cell Line, Tumor; Disease Models, Animal; Female; Ganglia, Spinal; Hyperalgesia; Immunoblotting; Injections, Spinal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pain; Pain Measurement; Phosphorylation; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2Y1; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord | 2012 |
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resorption; Carcinoma; Cell Adhesion; Cells, Cultured; Clopidogrel; Enzyme Activation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Osteoporosis; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Specific Pathogen-Free Organisms; Ticlopidine | 2012 |
S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
Topics: Adenosine Diphosphate; Animals; Bone Neoplasms; Cattle; Cell Division; Cysteine; Drug Design; HeLa Cells; Humans; Kinesins; Mitosis; ortho-Aminobenzoates; Osteosarcoma; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Spindle Apparatus; Stereoisomerism | 2006 |
Efficacy of aminohydroxypropylidene diphosphonate in the treatment of malignancy-associated hypercalcaemia.
Topics: Adenosine Diphosphate; Bone Neoplasms; Breast Neoplasms; Calcium; Drug Evaluation; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged | 1987 |